Publications by authors named "Els Dequeker"

Claim this Profile
T
The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
Nynke Willers, Patrick Neven, Giuseppe Floris, Cecile Colpaert, Eva Oldenburger, Els Dequeker

Clin Breast Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices.
Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert, Els Dequeker

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.
Mieke R Van Bockstal, Maxine Cooks, Iris Nederlof, Mariël Brinkhuis, Annemiek Dutman, Els Dequeker

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
Zandra C Deans, Jose Luis Costa, Ian Cree, Els Dequeker, Anders Edsjö

Virchows Arch· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres.
Annemarie Boleij, Véronique Tack, Aliki Taylor, George Kafatos, Sophie Jenkins-Anderson, Els Dequeker

BMC Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Sajantila and Budowle.
David E Barton, Mireille Claustres, Viktor Kozich, Els Dequeker, Brian Fowler

Eur J Hum Genet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic).
Mireille Claustres, Viktor Kožich, Els Dequeker, Brain Fowler, Jayne Y Hehir-Kwa

Eur J Hum Genet· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardized framework for the validation and verification of clinical molecular genetic tests.
Christopher J Mattocks, Michael A Morris, Gert Matthijs, Elfriede Swinnen, Anniek Corveleyn, Els Dequeker

Eur J Hum Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.
Els Dequeker, Manfred Stuhrmann, Michael A Morris, Teresa Casals, Carlo Castellani

Eur J Hum Genet· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of cells from cystic fibrosis patients in research. A model consent form.
Caroline Trouet, Ingrid Dreezen, Kris Dierickx, Jean-Jacques Cassiman, Els Dequeker

J Cyst Fibros· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CF or not CF? That is the question.
J A Dodge, Els Dequeker

J Cyst Fibros· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis